Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01394250 · ClinicalTrials.gov registry record · Phase 2
Vibrating, Cold Device for Pediatric Intravenous (IV) Cannulation Pain Relief
A Phase 2 study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Phase 2
- Development phase
- 240
- Enrollment target
NCT01394250 is a Phase 2 study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 240 participants.
The verdict
NCT01394250, a Phase 2 study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 240 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effectiveness of Buzzy®, a battery-powered reusable device that provides cold and vibration, in reducing the pain associated with intravenous (IV) cannulation. The investigators will investigate if Buzzy® is as effective as topical lidocaine cream in reducing the pain associated with IV cannulation.
Interventions
- DEVICE Buzzy
- DRUG Topical Lidocaine 4% Cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2011-06 |
| Est. Completion | 2013-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01394250
The ClinicalTrials.gov registry entry for NCT01394250 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Buzzy is the first listed.
NCT01394250 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01394250 about?
NCT01394250 is a clinical study titled "Vibrating, Cold Device for Pediatric Intravenous (IV) Cannulation Pain Relief". The purpose of this study is to test the effectiveness of Buzzy®, a battery-powered reusable device that provides cold and vibration, in reducing the pain associated with intravenous (IV) cannulation. The investigators will investigate if Buzzy® is as effective as topical lidocaine cream in reducing...
What is the current status of trial NCT01394250?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 240 participants. The study started on 2011-06. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01394250?
The interventions under investigation include: Buzzy (DEVICE), Topical Lidocaine 4% Cream (DRUG).
Who is sponsoring clinical trial NCT01394250?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.